[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6895 Introduced in House (IH)]

<DOC>






118th CONGRESS
  1st Session
                                H. R. 6895

To amend the National Defense Authorization Act for Fiscal Year 2023 to 
  extend Federal support for bioindustrial manufacturing processes to 
    include support for the manufacturing of certain pharmaceutical 
                              ingredients.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           December 22, 2023

 Ms. Slotkin introduced the following bill; which was referred to the 
                      Committee on Armed Services

_______________________________________________________________________

                                 A BILL


 
To amend the National Defense Authorization Act for Fiscal Year 2023 to 
  extend Federal support for bioindustrial manufacturing processes to 
    include support for the manufacturing of certain pharmaceutical 
                              ingredients.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Defense Production and Active 
Pharmaceutical Ingredients Act''.

SEC. 2. MODIFICATION OF SUPPORT FOR RESEARCH AND DEVELOPMENT OF 
              BIOINDUSTRIAL MANUFACTURING PROCESSES.

    Section 215(c)(1) of the James M. Inhofe National Defense 
Authorization Act for Fiscal Year 2023 (Public Law 117-263; 10 U.S.C. 
4841 note) is amended by inserting ``active pharmaceutical ingredients, 
key starting materials for such ingredients,'' after ``commodity 
chemicals,''.
                                 <all>